The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy

The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy

Platelet function tests (PFT), such as the Multiple Electrode Analyzer (Multiplate) and VerifyNow, show little concordance in patients using antiplatelet drugs. A major difference between these tests is the use of prostaglandin E1 (PGE1) to inhibit P2Y1-platelet-receptor activation in VerifyNow and...

Full description

Bibliographic Details
Main Authors: Anne-Marije Hulshof, Minka Vries, Paul Verhezen, Rick Wetzels, Mirella Haartmans, Renske Olie, Hugo Ten Cate, Yvonne Henskens
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Platelets
Subjects:
inhibitor percentage
multiplate adp
multiplate adp-hs
platelet function tests
prostaglandin e1
verifynow p2y12
Online Access:http://dx.doi.org/10.1080/09537104.2020.1754378

Similar Items

Similar Items